← Browse by Condition
Medical Condition
stage iva prostate cancer ajcc v8
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3
NCT04947254 Phase 2
Recruiting
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
Enrollment
200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05054296 Phase 2
Recruiting
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
Enrollment
200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05722288 Phase 2
Recruiting
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
Enrollment
60 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06650579 Phase 3
Recruiting
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Enrollment
72 pts
Location
United States
Sponsor
Emory University
NCT05168618 Phase 2
Recruiting
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Enrollment
33 pts
Location
United States
Sponsor
University of Utah